AgingResearch.News
Alzheimer's Research & Therapy

Eighteen-month real-world outcomes of lecanemab treatment and transition to maintenance therapy in early Alzheimer’s disease

By Noa Bregman, Talya Nathan, Mori Hai Levy, Show 5 more authorsTamara Shiner
Study in peopleInterventions
Paper

The paper

Noa Bregman, Talya Nathan, Mori Hai Levy, Show 5 more authorsTamara Shiner

Tel Aviv University

Alzheimer's Research & Therapy, 8 Oct 2026, CC BY-NC-ND

doi.org/10.1186/s13195-026-02224-z

Related